Patented genomics

The patent system is being used to monopolise the all the tools for genomics manipulation. In the US, for example, it costs a woman between $3,000 and $4,000 to be tested for familial breast cancer that is free in Europe to all women. This is because a corporation owns -in the US only- the patent […]

Continue Reading